Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Mark Hudson.

Newcastle AuthorsTitleYearFull text
Dr Sam Tingle
Dr Emily Thompson
Rodrigo Figueiredo
Dr Mark Hudson
Gourab Sen
et al.
Risk factors and impact of early anastomotic biliary complications after liver transplantation: UK registry analysis2021
Dr Mark Hudson
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System2019
Dr Mark Hudson
Hepatocellular Carcinoma as a Complication of Vascular Disease of the Liver After Fontan Procedure2019
Dr Abdullah Malik
Dr Steven Masson
Dr Mark Hudson
Professor Derek Manas
Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival2019
Dr Mark Hudson
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence2019
Dr Jess Dyson
Dr Mark Hudson
Paediatric to adult liver transition services: the state of play in the UK2019
Dr Mark Hudson
Dr James Orr
The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC)2019
Dr Jess Dyson
Dr Mark Hudson
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: Fourth report of the Lancet Standing Commission on Liver Disease in the UK2018
Dr Mark Hudson
Helen Jarvis
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK2018
Dr Mark Hudson
Helen Jarvis
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK2018
Dr Holly Standing
Helen Jarvis
Dr James Orr
Professor Catherine Exley
Dr Mark Hudson
et al.
General practitioners' experiences and perceptions of early detection of liver disease: a qualitative study in primary care2018
Dr Mark Hudson
Guidelines on the management of abnormal liver blood tests2018
Dr Sushma Saksena
Dr Mark Hudson
NCEPOD and alcohol-related liver disease, what are the views of those who deliver the service? A survey of consultants and trainees in North Eastern England2018
Dr Jess Dyson
Professor David Jones
Dr Mark Hudson
Primary sclerosing cholangitis2018
Dr Louise Coats
Dr John O'Sullivan
Dr David Crossland
Dr Beate Haugk
Dr Mark Hudson
et al.
Combined heart-liver transplantation for failing Fontan circulation in a late survivor with single-ventricle physiology.2017
Dr Beate Haugk
Dr Yvonne Bury
Dr Louise Coats
Dr John O'Sullivan
Dr Mark Hudson
et al.
Defining the role of liver biopsy in the assessment of liver fibrosis in patients with Fontan circulation2017
Dr Stuart McPherson
Dr Jess Dyson
Dr Mark Hudson
Editorial: improving in-hospital management of decompensated cirrhosis by a ‘care bundle’ – hope, frustration and lessons to learn. Authors’ reply2017
Dr Holly Standing
Helen Jarvis
Dr James Orr
Professor Catherine Exley
Dr Mark Hudson
et al.
How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences2017
Dr Jess Dyson
Dr Mark Hudson
New metrics for the Lancet Standing Commission on Liver Disease in the UK2017
Dr Mark Hudson
Should we screen for cirrhosis?2017
Dr Mark Hudson
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: A retrospective observational study (IMPRESS)2017
Dr James Orr
Dr Daniel Stow
Professor Fiona Matthews
Professor Barbara Hanratty
Professor David Jones
et al.
Eleven-year mortality and referral practices associated with abnormal alanine aminotransferase (ALT) results2016
Dr Louise Coats
Dr David Crossland
Dr Mark Hudson
Dr John O'Sullivan
Fontan conversion is a dated approach to the failing Fontan2016
Dr David Crossland
Dr Mark Hudson
Fontan-associated liver disease: Implications for heart transplantation2016
Dr Jess Dyson
Dr Chris Lamb
Dr Steven Masson
Dr Mark Hudson
Dr Christian Dipper
et al.
Implementation of a “care bundle” improves the management of patients admitted to hospital with decompensated cirrhosis2016
Dr James Orr
Dr Mark Hudson
Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data2016
Dr Stuart McPherson
Dr Jess Dyson
Dr Mark Hudson
Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h2016
Dr Mark Hudson
The Impact of Rifaximin-Alpha on NHS Hospital Resource Use in UK Patients with Hepatic Encephalopathy: A Retrospective Observational Study (Impress)2016
Dr James Orr
Dr Mark Hudson
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-alpha2016
Gourab Sen
Dr Mark Hudson
Professor Derek Manas
Umbilical Hernia Repair in Cirrhosis: Outcomes and Prognostic Factors in a Liver Transplant Unit2016
Dr James Orr
Dr Mark Hudson
Editorial: prolonged remission from hepatic encephalopathy with rifaximin2015
Dr Jess Dyson
Dr Steven Masson
Dr Stuart McPherson
Professor Derek Manas
Dr Mark Hudson
et al.
Experience of Using Advagraf in a Single Liver Transplant Centre in the United Kingdom2015
Dr Jess Dyson
Dr Ahmed Elsharkawy
Dr Chris Lamb
Dr Ahmad Al-Rifai
Professor Julia Newton
et al.
Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output2015
Dr Jess Dyson
Dr Steven Masson
Dr Stuart McPherson
Dr Mark Hudson
Impact of a Nurse-Led Annual Review Clinic for Liver Transplant Recipients2015
Dr Jess Dyson
Dr Chris Lamb
Dr Mark Hudson
Dr Stuart McPherson
Implementation and impact of a care bundle for the management of patients with decompensated liver disease2015
Dr Jess Dyson
Dr Mark Hudson
Implementation of the Lancet Standing Commission on Liver Disease in the UK2015
Dr Jess Dyson
Dr Stuart McPherson
Dr Steven Masson
Dr Mark Hudson
Importance of Health Education in an Annual Review Liver Transplant Clinic in the United Kingdom2015
Dr James Orr
Professor David Jones
Dr Mark Hudson
Minimally deranged serum alanine transferase identified in the community: referral practices, prevalence of liver pathology and long term mortality2015
Dr James Orr
Dr Mark Hudson
Emeritus Professor Calum McNeil
Professor David Jones
The home study (home monitoring in encephalopathy): Rationale and study design2015
Dr James Orr
Dr Mark Hudson
The impact on hospital resource utilisation of Rifaximin-alpha for hepatic encephalopathy in routine clinical practice: Real world data from seven UK liver centres2015
Dr Mark Hudson
UK guidelines on the management of variceal haemorrhage in cirrhotic patients2015
Stuart Robinson
Dr Steven Masson
Dr Mark Hudson
Professor Derek Manas
Umbilical hernia repair in cirrhosis: outcomes and prognostic factors in a liver transplant unit2015
Dr Jess Dyson
Dr Mark Hudson
Professor Derek Manas
Dr Steven Masson
A Positive Complement Dependent Cytotoxic (CDC) Crossmatch Does Not Impact on Patient Survival or Increase the Risk of Acute Cellular Rejection, or Biliary Strictures after Liver Transplantation2014
Dr Mark Hudson
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis2014
Dr Steven Masson
Dr Stuart Kendrick
Dr Ahmed Elsharkawy
Dr Mark Hudson
An 'alcohol contract' has no significant effect on return to drinking after liver transplantation for alcoholic liver disease2014
Dr James Orr
Dr Mark Hudson
Professor David Jones
Development and validation of The Newcastle Patient Reported Ascites Measure2014
Dr James Orr
Tara Homer
Dr Laura Ternent
Professor Julia Newton
Emeritus Professor Calum McNeil
et al.
Health related quality of life in people with advanced chronic liver disease2014
Dr James Orr
Tara Homer
Dr Laura Ternent
Professor Julia Newton
Emeritus Professor Calum McNeil
et al.
'Health Related Quality of Life in People with Advanced Chronic Liver Disease'2014
Dr Jess Dyson
Dr Mark Hudson
Dr Stuart McPherson
Lesson of the month 2: Severe reactivation of hepatitis B after immunosuppressive chemotherapy2014
Dr James Orr
Tara Homer
Dr Laura Ternent
Professor Luke Vale
Dr Mark Hudson
et al.
PTU-112 Associations Between Healthcare Resource Utilisation And Health-related Quality Of Life In Cirrhosis2014
Professor Quentin Anstee
Dr Mark Hudson
Professor Helen Reeves
Reply to "Hepatocellular carcinoma and the Newcastle-upon-Tyne area"2014
Dr James Orr
Dr Mark Hudson
Resource use associated with hepatic encephalopathy in patients with liver disease2014
Dr James Orr
Dr Mark Hudson
Resource Use Associated with Hepatic Encephalopathy in Patients with Severe Liver Disease2014
Dr James Orr
Dr Mark Hudson
Rifaximin is Efficacious in the Treatment of Chronic Overt Hepatic Encephalopathy: A UK Liver Multi-Centre Experience2014
Dr James Orr
Dr Yvonne Bury
Dr Mark Hudson
Dr Steven Masson
Liver transplantation for acute liver failure caused by macrophage activation syndrome2013
Dr Stuart McPherson
Dr Samuel Moses
Dr Shafiq Rehman
Claire Miller
Dr Mark Hudson
et al.
A pilot of targeted case finding for hepatitis B virus (HBV) and hepatitis C (HCV) in the British South Asian community2012
Dr Stuart Kendrick
Dr Ahmed Elsharkawy
Dr Mark Hudson
Dr Steven Masson
An “alcohol contract” has not reduced rates of post-transplant drinking following transplantation for alcoholic liver disease2012
Dr Ahmed Elsharkawy
Dr Stuart McPherson
Dr Steven Masson
Professor Alastair Burt
Dr Mark Hudson
et al.
Lesson of the Week: Cholestasis secondary to anabolic steroid use in young men2012
Dr Enid Michael
Dr Andrew Turley
Dr Samuel Moses
Dr Mark Hudson
Professor Margaret Bassendine
et al.
Pregnant mothers with chronic hepatitis B (HBV): how often is treatment needed?2012
Dr James Prentis
Professor Derek Manas
Professor Mike Trenell
Dr Mark Hudson
Dr Christopher Snowden
et al.
Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation2012
Dr Imran Patanwala
Professor Julia Newton
Dr Mark Hudson
Professor David Jones
The clinical impact of varices and a new externally validated non-invasive inexpensive tool to predict their presence in patients with PBC2012
Dr Imran Patanwala
Dr Simon Kometa
Professor Julia Newton
Dr Mark Hudson
Professor David Jones
et al.
An externally-validated clinical tool for the prediction of gastro-oesophageal varices in patients with PBC - the Newcastle varices in PBC (NVP) score2011
Dr Imran Patanwala
Dr Mark Hudson
Are UK gastroenterology trainees confident in managing hepatology?2011
Professor Julia Newton
Dr Mark Hudson
Professor David Jones
Morbidity and mortality associated with varices in patients with primary biliary cirrhosis2011
Dr Imran Patanwala
Professor Derek Manas
Dr Mark Hudson
Professor Helen Reeves
NAFLD and the changing face of hepatocellular cancerER (HCC)2011
Dr Imran Patanwala
Dr John Rose
Bryon Jaques
Professor Derek Manas
Dr Mark Hudson
et al.
NAFLD related HCC is rising dramatically in the North of England2011
Dr Stuart McPherson
Professor Derek Manas
Dr Mark Hudson
Dr Stephen Stewart
Outcomes of liver transplantation for alcoholic liver disease are good, but cancer is a frequent cause of death2011
Dr Imran Patanwala
Dr Mark Hudson
The current state of hepatology training in UK: Results form a national trainee survey2011
Dr Stuart McPherson
Dr Mark Hudson
Professor Margaret Bassendine
Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England2011
Dr Stuart McPherson
Dr Mark Hudson
Professor Margaret Bassendine
Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England2011
Dr Mark Hudson
Acute liver failure: Current european perspective2010
Dr Imran Patanwala
Dr Mark Hudson
Hepatology training in the United Kingdom - results of a national trainees' survey2010
Dr Imran Patanwala
Dr Mark Hudson
How confident are UK gastroenterology trainees in managing liver conditions?2010
Dr Mark Hudson
Dr Stuart McPherson
Professor Alastair Burt
Professor Margaret Bassendine
Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus2010
Dr Mark Hudson
Dr Stuart McPherson
Professor Alastair Burt
Professor Margaret Bassendine
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus2010
Dr Joseph Gray
Dr Dipanker Chattopadhyay
Dr Gary Beale
Dr Gillian Patman
Dr Luca Miele
et al.
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease2009
Dr Ahmad Al-Rifai
Dr Martin Prince
Professor Julia Newton
Dr Mark Hudson
Fatigue in PSC Patients With and Without Inflammatory Bowel Disease2009
Dr Stuart Kendrick
Dr Mark Hudson
Dr Stephen Stewart
White Cell Count and Platelet Count Associate with Histological Alcoholic Hepatitis in Jaundiced Harmful Drinkers2009
Dr Gary Beale
Dr Dipanker Chattopadhyay
Dr Joseph Gray
Dr Stephen Stewart
Dr Mark Hudson
et al.
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease2008
Dr Helen Marshall
Dr Helen Robertson
Professor Alastair Burt
Professor David Jones
Professor John Kirby
et al.
Biliary epithelial to mesenchymal transition contributes to portal tract fibrogenesis in primary sclerosing cholangitis2008
Professor John Kirby
Dr Helen Robertson
Dr Helen Marshall
Dr Karolina Rygiel
Dr Mark Hudson
et al.
Epithelial to mesenchymal transition in primary sclerosing cholangitis2008
Professor John Kirby
Dr Helen Robertson
Helen Marshall
Dr Karolina Rygiel
Dr Mark Hudson
et al.
Epithelial to mesenchymal transition in primary sclerosing cholangitis2008
Dr Martin Prince
Professor Margaret Bassendine
Dr Mark Hudson
Emeritus Professor Oliver James
Professor David Jones
et al.
A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis2007
Leo Smith
Bryon Jaques
Dr Kaushik Agarwal
Dr Mark Hudson
David Talbot
et al.
Do laparoscopy and intraoperative ultrasound have a role in the assessment of patients with end-stage liver disease and hepatocellular carcinoma for liver transplantation?2007
Dr Mark Hudson
Professor Simon Thomas
Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds2007
Dr Mark Hudson
Professor Simon Thomas
Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds2007
Dr Mark Hudson
Minimally-elevated liver function tests: Are we seeing or doing enough?2007
Dr Mark Hudson
Professor Derek Manas
Non-transplant surgery for dominant stricture in primary sclerosing cholangitis: Revisited2007
Professor Julia Newton
Dr Mark Hudson
Jessie Pairman
Professor David Jones
Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis2007
Professor Alastair Burt
Dr Mark Hudson
Professor Margaret Bassendine
The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.2007
Dr Mark Hudson
An alcoholic patient who continues to drink: endoscopic treatment is preferred2006
Dr Neil Rajan
Dr Andrew Carmichael
Dr Michael Bramble
Dr Mark Hudson
Cutaneous xanthomatosis: a novel presentation of hypercholesterolaemia in primary sclerosing cholangitis2006
Dr Kaushik Agarwal
Professor Derek Manas
Dr Mark Hudson
How good are we at minimising cardiovascular risk following orthotopic liver transplant?2006
Dr Kaushik Agarwal
Professor Derek Manas
Dr Mark Hudson
MELD, MELD-s and donor graft quality do not predict patient or graft survival post liver transplant.2006
Dr Mark Hudson
Joanne Newton
Dr Martin Prince
Professor David Jones
An evidence-based model for the targeting of varices screening in PBC2005
Professor Jeremy Parr
Dr Mark Hudson
Audit of acute variceal bleeding in a tertiary referral centre2005
Dr Fraser Charlton
Dr Mark Hudson
Dr Clifford Lawrence
Cutaneous calcification following liver transplantation2005
Dr Mark Hudson
Dr Christopher Snowden
Dr Ahmed Chishti
Professor Derek Manas
Dr Kaushik Agarwal
et al.
Liver transplantation in acute liver failure: Intracranial pressure monitoring optimizes patient selection and outcome2005
Richard Charnley
Mark Griffin
Nick Hayes
Dr Mark Hudson
Dr Kenneth Matthewson
et al.
One year prospective audit of ERCP across one hospital trust2005
Dr Mark Hudson
Post orthoptic liver transplant complications in primary sclerosing cholangitis2005
Dr Mark Hudson
Professor Simon Thomas
[abstract] Inappropriate delay in acetylycysteine administration in patients with paracetamol overdose who subsequently develop severe liver dusfunction2004
Dr Mark Hudson
Professor Simon Thomas
Frequency of serious hepatic dysfunction when paracetamol concentrations are below current United Kingdom nomogram treatment lines2004
Dr Mark Hudson
UK legislation on analgesic packs: before and after study of long term effect on poisonings2004
Dr Martin Prince
Emeritus Professor Oliver James
Professor Chris Day
Dr Mark Hudson
Professor David Jones
et al.
Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience2003
Dr Martin Prince
Dr Mark Hudson
Professor Chris Day
Emeritus Professor Oliver James
Professor David Jones
et al.
Pain as a complication of use of opiate antagonists for symptom control in cholestasis2003
Dr Martin Prince
Dr Peter Donaldson
Dr Mark Hudson
Survival in patients with primary sclerosing cholangitis (PSC). A comparitive study of available prognostic indices2003
Professor David Jones
Dr Martin Prince
Dr Mark Hudson
The Mayo prognostic score fails to predict increased mortality associated with portal hypertension in primary biliary cirrhosis (PBC)2003
Professor John Kirby
Michael Bone
Dr Helen Robertson
Dr Mark Hudson
Professor David Jones
et al.
The number of intraepithelial T cells decreases from ascending colon to rectum [1]2003
Dr Mark Hudson
Dr Katherine Orr
A mass in the liver2002
Dr Martin Prince
Dr Mark Hudson
Alcoholic hepatitis with ascites may mimic advanced ovarian malignancy2002
Dr Martin Prince
Dr Mark Hudson
Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages2002
Dr Kaushik Agarwal
Professor David Jones
Professor Alastair Burt
Dr Mark Hudson
Emeritus Professor Oliver James
et al.
Metastatic breast carcinoma presenting as acute liver failure and portal hypertension2002
Alison Sutherland-Craggs
Dr John Mansfield
Dr Mark Hudson
Professor Ann Daly
Emeritus Professor Roger Francis
et al.
Osteoporosis in Crohn's disease is not determined by NOD2 genotype [abstract]2002
Dr Martin Prince
Emeritus Professor Oliver James
Professor Chris Day
Dr Mark Hudson
Professor David Jones
et al.
Pain as a complication of opiate antagonist therapy in cholestasis: A single centre experience2002
Dr Mark Hudson
Michael Thick
Sheridan Pollard
Dr Aiste McCormick
Tacrolimus versus microemulsified cyclosporine in liver transplantation - The TMC randomised trial. Final results at one year2002
Professor David Jones
Dr Martin Prince
Dr Mark Hudson
The impact of portal hypertension in primary biliary cirrhosis (PBC)2002
Professor David Jones
Dr Martin Prince
Dr Mark Hudson
The mayo prognostic score fails to predict increased mortality associated with portal hypertension in primary biliary cirrhosis2002
Professor David Jones
Dr Martin Prince
Dr Mark Hudson
The prevalence of portal hypertension (PHT) in primary biliary cirrhosis (PBC) [abstract]2002
Dr Ann Curtis
Dr Mark Welfare
Dr Mark Hudson
Dr Peter Donaldson
Dr John Mansfield
et al.
Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and crohn disease in multiple populations from northeast England2001
Professor Chris Day
Julian Leathart
Professor Ann Daly
Dr Mark Hudson
Association of a 5'-flanking region polymorphism in the interleukin-4 gene with Crohn’s disease in a British population.2001
Professor Chris Day
Julian Leathart
Professor Ann Daly
Dr Mark Hudson
Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population2001
Dr Stephen Stewart
Dr Mark Hudson
David Talbot
Professor Derek Manas
Professor Chris Day
et al.
Mycophenolate mofetil monotherapy in liver transplantation2001
Dr Kaushik Agarwal
Professor Ann Daly
Julian Leathart
Dr Mark Hudson
Professor Chris Day
et al.
Polymorphisms of immunoregulatory genes: A step towards individually tailored immunosuppression?2001
Dr Alison Sutherland
Professor Chris Day
Dr Mark Welfare
Professor Ann Daly
Dr John Mansfield
et al.
Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease2001
Vicki Strugala
Paul Hainsworth
Dr Mark Bennett
Dr Mark Hudson
Professor Jeffrey Pearson
et al.
Thickness and continuity of the human colonic mucus layer is decreased in active UC but remains normal in quiescent UC2001
Dr Kaushik Agarwal
Dr John Rose
Dr Mark Hudson
Professor David Jones
TIPSS in PBC: Lessons regarding the role played by variceal bleeding in disease prognosis2001
Professor John Magee
Dr Mark Hudson
Professor Derek Manas
Professor Kate Gould
Dr Katherine Orr
et al.
Tuberculosis transmitted through transplantation2001
Dr Nicholas Thompson
Dr Christopher Record
Dr Mark Hudson
Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment?2000
Dr Kofi Oppong
Dr Mark Hudson
Dr Christopher Record
Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial2000
Dr Martin Prince
Professor Simon Thomas
Emeritus Professor Oliver James
Dr Mark Hudson
Reduction in incidence of severe paracetamol poisoning2000
Dr Martin Prince
Professor Simon Thomas
Emeritus Professor Oliver James
Dr Mark Hudson
Restrictions in availability of paracetamol (PAR) have been associated with a reduction in the incidence of PAR induced liver failure2000
Michael Bone
Professor John Kirby
Dr Helen Robertson
Professor Alastair Burt
Dr Mark Hudson
et al.
Ulcerative colitis: An investigation of the potential role played by a B-E(7) +VE T-cells2000
Dr Kaushik Agarwal
Professor David Jones
Professor Ann Daly
Professor Margaret Bassendine
Dr Mark Hudson
et al.
CTLA-4 gene polymorphism and susceptibility to inflammatory bowel disease (IBD)1999
Professor David Jones
Emeritus Professor Oliver James
Professor Alastair Burt
Dr Mark Hudson
Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis1999
Dr Sarah Jowett
Dr John Tapson
Dr Mark Hudson
Neill Thompson
Gastric wall haematoma as a complication of percutaneous endoscopic gastrostomy insertion1999
Dr Nicholas Thompson
Dr Richard Lendrum
Dr Mark Hudson
Paul Hainsworth
Emeritus Professor Roger Francis
et al.
Osteoporosis in Crohn's disease: A systematic study of patients in the north east of England1999
Dr John Rose
Emeritus Professor Oliver James
Dr Mark Hudson
Portal hypertension secondary to arterioportal fistulae: two unusual cases1999
Dr Kaushik Agarwal
Professor Derek Manas
Dr Mark Hudson
Terbinafine and fulminant hepatic failure1999
Professor Helen Reeves
Professor Derek Manas
Professor Margaret Bassendine
Dr Mark Hudson
Emeritus Professor Oliver James
et al.
Intravenous bisphosphonate pre liver transplant prevents osteoporotic vertebral collapse1996